Active ingredients of dual-action Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol now delivered by new propellant-free inhaler RIDGEFIELD, Conn., Oct. 10, 2011 | Active ...

Ipratropium bromide 0.06% (42mcg/spray); aqueous soln. Ipratropium bromide, an anticholinergic (parasympatholytic) agent, has antisecretory properties which inhibit secretions from the serous and ...

Objectives: To compare the efficacy and tolerability of formoterol (12 or 24µg twice daily) alone with combined ipratropium bromide and fenoterol in the treatment of chronic obstructive pulmonary ...

Ipratropium bromide 20mcg, albuterol 100mcg (equivalent to 120mcg albuterol sulfate); per actuation; inhalation spray; CFC-free. Based on studies, ipratropium bromide appears to inhibit vagally ...

Short-acting Anticholinergic Drugs in Asthma Ipratropium bromide was introduced into the management of obstructive airway diseases in the mid-1970s.

Ipratropium bromide also may cause urinary retention. COMBIVENT should be used with caution in patients with narrow-angle glaucoma, prostatic hyperplasia, or bladder-neck obstruction.

About Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol COMBIVENT Inhalation Aerosol is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on ...

Medications that are commonly administered through a nebuliser include bronchodilators (for example, salbutamol), anticholinergics (for example, ipratropium bromide), corticosteroids (for example, ...

Ipratropium bromide, a component of COMBIVENT Inhalation Aerosol and COMBIVENT RESPIMAT, is an anticholinergic and may cause urinary retention.